Year: 2015
Type: article
Abstract: BACKGROUND: Studies using neuroimaging and in vivo microdialysis in humans and nonhuman primates indicate that inflammatory cytokines such as interferon-alpha reduce dopamine release in the ventral striatum in association with depressive symptoms including anhedonia and psychomotor slowing. METHODS: Herein, we examined whether reduced striatal dopamine release in rhesus monkeys chronically treated with interferon-alpha can be restored by administration of the dopamine precursor levodopa via reverse in vivo microdialysis. RESULTS: Levodopa completely reversed interferon-alpha-induced reductions in striatal dopamine release. No changes were found in the 3,4-dihydroxyphenylacetic acid to dopamine ratio, which increases when unpackaged dopamine is metabolized via monoamine oxidase. CONCLUSIONS: These findings suggest that inflammatory cytokines reduce the availability of dopamine precursors without affecting end-product synthesis or vesicular packaging and/or release and provide the foundation for future studies investigating therapeutic strategies that facilitate availability of dopamine precursors to improve depressive symptoms in patient populations with increased inflammation.
DOI: 10.1093/ijnp/pyu084
Institutions: Emory University, Winship Cancer Institute
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,693
Awards: Dopaminergic Mechanisms of Cytokine-Induced Behavioral Change, Cytokine Effects on Amphetamine-Induced Dopamine Release using PET Neuroimaging, G4663421645, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, Atlanta Clinical and Translational Science Institute (ACTSI) Renewal, HIV/AIDS Clinical Research Training Program, Pathology and Treatment of Cytokine-Induced Depression
OpenAlex ID: W1980305473
